http://www.iGuard.org A summary of the most recent drug safety alerts for prescription medicines. en-us 2010-03-17T10:34:27-05:00 support@iGuard.org iGuard RSS generator http://www.iguard.org/alerts/alert/840.html The U.S. Food and Drug Administration (FDA) has ordered Glenmark Generics and Konec Inc. to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3... 2010-03-17T10:34:27-05:00 http://www.iguard.org/alerts/alert/839.html Kirk Pharmaceuticals, LLC is recalling a single lot of diphenhydramine HCL 25 mg capsules sold over-the-counter (OTC). Lot number BK549 is being recalled because routine testing of capsules in this lot found capsules that were less potent. The loss of ... 2010-03-17T19:20:22-05:00 http://www.iguard.org/alerts/alert/838.html Cadista Pharmaceuticals, Inc has finished its recall of a single lot of Terazosin HCl Capsules, 5 mg. Lot number 9P050 was recalled because this lot may have been packaged with two dosage strengths of the same drug. Terazosin is commonly used in ... 2010-03-16T18:26:59-05:00 http://www.iguard.org/alerts/alert/836.html Novartis Pharmaceuticals Corp. is recalling a single lot of Amlodipine Besylate and Benazepril HCl Capsules, 5mg/10mg (equivalent to amlodipine 5 mg and benazepril 10 mg) made by Sandoz. Lot number F1031 is being recalled because routine testing of sam... 2010-03-17T15:59:36-05:00 http://www.iguard.org/alerts/alert/835.html Paddock Laboratories, Inc. is recalling two lots of Compro prochlorperazine suppositories, USP 25 mg. Lot numbers 9116177 and 8172830 are being recalled because samples from these lots failed tests that measured their ability to dissolve. Compro c... 2010-03-16T15:13:09-05:00 http://www.iguard.org/alerts/alert/833.html The U.S. Food and Drug Administration (FDA) announced that it will review the primary results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Trial. The ACCORD Lipid Trial evaluated the potential heart related benefits in pati... 2010-03-15T17:12:03-05:00 http://www.iguard.org/alerts/alert/832.html The U.S. Food and Drug Administration (FDA) today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who are "poor metabolizers" and ... 2010-03-13T02:27:24-05:00 http://www.iguard.org/alerts/alert/831.html Patients and healthcare professionals may have questions about oral bisphosphonate medications and fractures, specifically atypical subtrochanteric femur fractures which is a fracture in the bone just below the hip joint. Oral bisphosphonates are commo... 2010-03-11T22:54:07-05:00 http://www.iguard.org/alerts/alert/830.html Cangene, Baxter and the FDA notified healthcare professionals that cases of intravascular hemolysis (IVH) and its serious complications, including death, have been reported in patients treated for immune thrombocytopenic purpura (ITP) with WinRho SDF. ... 2010-03-11T15:08:26-05:00 http://www.iguard.org/alerts/alert/829.html In April 2010, the name Kapidex (dexlansoprazole) will be changing to Dexilant (dexlansoprazole). Kapidex is a proton pump inhibitor used to treat heartburn and other conditions by reducing the amount of acid produced in the stomach. Since its appro... 2010-03-05T16:11:54-05:00